Urologic Cancer Clinical Trials

9 recruiting

Urologic Cancer Trials at a Glance

9 actively recruiting trials for urologic cancer are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Bodø, Boston, and Drammen. Lead sponsors running urologic cancer studies include IRCCS San Raffaele, Institute of Oncology Ljubljana, and Dana-Farber Cancer Institute.

Browse urologic cancer trials by phase

Treatments under study

About Urologic Cancer Clinical Trials

Looking for clinical trials for Urologic Cancer? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Urologic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Urologic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Breast CancerGynecologic CancerUrologic Cancer
Institute of Oncology Ljubljana30 enrolled1 locationNCT07416630
Recruiting
Phase 2Phase 3

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Urologic CancerVenous Thromboembolism
Ottawa Hospital Research Institute120 enrolled1 locationNCT05920343
Recruiting
Not Applicable

Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors

Gynecologic CancerUrologic CancerGastrointestinal Cancer
Sykehuset Telemark200 enrolled11 locationsNCT06398314
Recruiting

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach(Radiogenomics-Urinary)

Urologic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology150 enrolled1 locationNCT06537037
Recruiting

PROM Project Urology

SurgeryUrologic CancerUrologic Diseases
Medical University of Graz47 enrolled1 locationNCT06397287
Recruiting
Not Applicable

The Man Van Project

Prostate CancerUrologic CancerBladder Cancer+8 more
Royal Marsden NHS Foundation Trust4,000 enrolled1 locationNCT06357416
Recruiting

Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies

Urologic CancerInfertilityUrologic Diseases
IRCCS San Raffaele15,000 enrolled1 locationNCT06187870
Recruiting
Not Applicable

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Prostate CancerUrologic CancerBladder Cancer+5 more
Dana-Farber Cancer Institute10 enrolled1 locationNCT05899361
Recruiting
Phase 2

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy

Urologic CancerBiochemical Recurrence of Malignant Neoplasm of Prostate
Prof. Dr. med. Christian Gratzke49 enrolled1 locationNCT04931979